Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | WEE1 | P30291 | 12/20 | 0.63 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 6/20 | 0.43 |
| ▸ | CSF1R | P07333 | 6/20 | 0.43 |
| ▸ | JAK2 | O60674 | 1/20 | 0.43 |
| ▸ | SRC | P12931 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Potrasertib SCHEMBL29859319 | 1.00 | WEE1 (0.63) | WEE1KCNH2EGFRCSF1RJAK2 | |
| Potrasertib SCHEMBL21373352 | 1.00 | WEE1 (0.63) | WEE1KCNH2EGFRCSF1RJAK2 | |
| Potrasertib SCHEMBL23246139 | 1.00 | WEE1 (0.63) | WEE1KCNH2EGFRCSF1RJAK2 | |
| Potrasertib SCHEMBL29506543 | 1.00 | WEE1 (0.63) | WEE1KCNH2EGFRCSF1RJAK2 | |
| SCHEMBL29506471 | 0.95 | WEE1 (0.63) | WEE1KCNH2EGFRCSF1RJAK2 | |
| SCHEMBL21373331 | 0.95 | WEE1 (0.63) | WEE1KCNH2EGFRCSF1RJAK2 | |
| SCHEMBL30732422 | 0.95 | WEE1 (0.63) | WEE1KCNH2EGFRCSF1RJAK2 | |
| SCHEMBL27131392 | 0.95 | WEE1 (0.63) | WEE1KCNH2EGFRCSF1RJAK2 | |
| Potrasertib SCHEMBL23246122 | 0.95 | WEE1 (0.61) | WEE1KCNH2EGFRCSF1RJAK2 | |
| SCHEMBL21373333 | 0.95 | WEE1 (0.59) | WEE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3543242-B1 | 8,9-DIHYDROIMIDAZOLE[1,2-A]PYRIMIDO[5,4-E]PYRIMIDINE-5(6H)-KETONE COMPOUND | IMPACT THERAPEUTICS SHANGHAI INC (CN) | 2024-01-03 | — | — | EP | disclosed |